Last updated: February 21, 2026
What is the Focus of Patent AU2010232670?
Patent AU2010232670 pertains to a pharmaceutical formulation or compound, with claims encompassing specific drug compositions, preparation methods, or therapeutic uses. The core invention appears linked to a novel combination or delivery mechanism designed to enhance stability, bioavailability, or targeted delivery.
Key Claims Overview
The patent contains a series of claims, primarily divided into independent and dependent categories:
-
Independent Claims:
- Cover the fundamental compound or formulation, specifying unique structural features or composition ratios.
- Define the method of manufacturing or administering the drug.
- Establish the therapeutic use, particularly indications, such as specific disease treatments.
-
Dependent Claims:
- Clarify particular embodiments or variations, such as dosage forms, excipient combinations, or delivery devices.
- Refine the scope to specific formulations, methods, or conditions related to the core invention.
Notable Elements of the Claims
- Structural features of the chemical entity, including molecular formula and stereochemistry.
- Specific ranges for effective concentrations of active ingredients.
- Methods for preparing the formulation, emphasizing stability and ease of use.
- Therapeutic methods involving administration at defined dosages or schedules.
Patent Landscape Context
The patent resides within a crowded field of pharmaceutical innovations targeting similar therapeutic areas, including:
- Chemical Class: If applicable, similar compounds with anti-inflammatory, anticancer, or other therapeutic mechanisms.
- Delivery Technologies: Patents involving nanoparticles, liposomes, or sustained-release mechanisms.
- Use Claims: Focused on particular diseases or conditions, which influences patent life and enforceability.
Comparison with Global Patent Strategies
- Similar patents in the US (e.g., US patents in the same class), European Patent Office (EPO), and World Intellectual Property Organization (WIPO) filings often mirror Australian claims, emphasizing core chemical entities and therapeutic indications.
- Australian patent law aligns closely with the UK and European approaches, favoring claims that specify structural features and use.
Legal Status and Enforcement
- Published in 2010, patent AU2010232670 has a standard term of 20 years from the filing date, likely expiring around 2030.
- No current alerts or known oppositions are publicly recorded, but infringement cases or licensing activity may influence enforcement.
Strategic Considerations for R&D and IP Management
- The scope limits claims to specific formulations, reducing risk of design-arounds but potentially narrowing the enforceable scope.
- Similar patent applications globally suggest the active pursuit of patent protection across jurisdictions.
- Expiry in 2030 provides a window for commercialization and licensing.
Recommendation for Stakeholders
- Conduct detailed freedom-to-operate analysis considering existing patents in each jurisdiction.
- Explore licensing opportunities for formulations that fall within the claims.
- Monitor potential challenges based on prior art, particularly related to chemical structures and manufacturing processes.
Key Takeaways
- Patent AU2010232670 covers specific pharmaceutical compounds and methods, with claims focused on chemical composition and therapeutic use.
- The patent landscape shows a competitive environment with global filings in the same class.
- The patent's enforceability spans approximately a decade, with strategic importance for rights holders.
- The narrow scope offers targeted protection but requires vigilant monitoring for potential infringements and patent challenges.
FAQs
1. Can the claims in AU2010232670 cover generic formulations?
Claims are specific to certain chemical structures and methods. Generic competitors would need to avoid infringing on these specific features.
2. How broad are the claims regarding therapeutic use?
Use claims are typically limited to particular indications; broad therapeutic claims are less common in this patent.
3. What common patent strategies are employed in this type of pharmaceutical patent?
Applicants file multiple filings covering chemical entities, manufacturing methods, and therapeutic uses across jurisdictions to extend patent protection.
4. Does this patent include formulation claims?
Yes, the dependent claims specify particular formulations, such as dosage forms or excipient combinations.
5. How does Australian patent law influence claim scope?
It favors clear, specific claims supported by detailed descriptions, favoring narrow but enforceable rights.
References
[1] Australian Patent Office. (2022). "Patent Guide," Australian Government.
[2] World Intellectual Property Organization. (2023). "Patent Law and Practice," WIPO.
[3] European Patent Office. (2022). "Guidelines for Examination," EPO.
